Coverage Initiated by Brookline Capital Acquisition Corp. for Adial Pharmaceuticals (NASDAQ:ADIL)

Stock analysts at Brookline Capital Acquisition Corp. initiated coverage on shares of  Adial Pharmaceuticals (NASDAQ:ADIL) in a report issued on wednesday. The brokerage set a Buy rating on the Medical stock.

View More Coverage Initiated by Brookline Capital Acquisition Corp. for Adial Pharmaceuticals (NASDAQ:ADIL)